{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SYN1",
        "Protein_Change": {
          "ref": "G",
          "alt": "G",
          "position": "Exon 4"
        },
        "variant_string_id": "SYN1_4"
      },
      "steps": [
        {
          "step": "Define Disease Mechanism",
          "description": "a-synuclein inhibits PLD2, and the study links this to pathogenicity."
        },
        {
          "step": "Assess Assay Applicability",
          "description": "In vitro experiments measure PLD2 inhibition, relevant to the disease mechanism."
        },
        {
          "step": "Evaluate Controls",
          "description": "Wild-type and mutant proteins used as controls, with 3 total controls (a, b, g)."
        },
        {
          "step": "Determine OddsPath",
          "description": "No direct OddsPath values, but 3 controls <11, leading to PS3_moderate."
        }
      ],
      "strength": "PS3_moderate"
    },
    {
      "variant_id": {
        "Gene": "SYN1",
        "Protein_Change": {
          "ref": "G",
          "alt": "A",
          "position": "Position 30"
        },
        "variant_string_id": "SYN1_30"
      },
      "steps": [
        {
          "step": "Define Disease Mechanism",
          "description": "Mutant A30P shows enhanced PLD2 inhibition compared to wild-type."
        },
        {
          "step": "Assess Assay Applicability",
          "description": "In vitro experiments measure PLD2 inhibition, relevant to the disease mechanism."
        },
        {
          "step": "Evaluate Controls",
          "description": "Wild-type and mutant proteins used as controls, with 3 total controls (a, b, g)."
        },
        {
          "step": "Determine OddsPath",
          "description": "No direct OddsPath values, but 3 controls <11, leading to PS3_moderate."
        }
      ],
      "strength": "PS3_moderate"
    },
    {
      "variant_id": {
        "Gene": "SYN1",
        "Protein_Change": {
          "ref": "G",
          "alt": "T",
          "position": "Position 53"
        },
        "variant_string_id": "SYN1_53"
      },
      "steps": [
        {
          "step": "Define Disease Mechanism",
          "description": "Mutant A53T shows enhanced PLD2 inhibition compared to wild-type."
        },
        {
          "step": "Assess Assay Applicability",
          "description": "In vitro experiments measure PLD2 inhibition, relevant to the disease mechanism."
        },
        {
          "step": "Evaluate Controls",
          "description": "Wild-type and mutant proteins used as controls, with 3 total controls (a, b, g)."
        },
        {
          "step": "Determine OddsPath",
          "description": "No direct OddsPath values, but 3 controls <11, leading to PS3_moderate."
        }
      ],
      "strength": "PS3_moderate"
    }
  ]
}